ArticleInfectious disorders drug targets2024

A New-fangled COVID-19 Variant, Eris, Might be the One to Lookout in 2023 or far from Over.

Suman Kumar Ray et al.PubMed ↗Publisher ↗

No numbers read from the abstract.